Foundayo Weight Loss Results: A Deep Dive

When it came to market in 2026, Foundayo became only the second oral GLP-1 medication to be licensed for weight loss and type 2 diabetes in the UK, behind the Wegovy pill. Containing the active ingredient orforglipron, the medication is made by Eli Lilly, the company behind Mounjaro injections.

Foundayo’s launch was significant for several reasons. Its presentation as an oral tablet means it could be a more appealing option to individuals who are unsure about injecting themselves, while its straightforward administration method sets it apart from the stricter regimen required by the Wegovy pill. Finally, as a GLP-1 medication, it should offer greater weight loss potential than other pills such as Mysimba and Xenical. But exactly how effective is Foundayo for weight loss?

Join us as we explore some key Foundayo weight loss results, offer a brief insight into how it works, examine how quickly you can lose weight on the medication, and much more. Let’s begin.

START YOUR CONSULTATION TODAY

Is Foundayo Effective for Weight Loss?

Foundayo contains the active ingredient orforglipron, a small-molecule GLP-1 receptor agonist that can be highly effective for weight reduction. Its weight-loss benefits are broadly comparable to other GLP-1 medicines, with clinical trial participants losing an average of 12.4% of their body weight on the highest dose. Foundayo also produced clinically meaningful improvements in patients’ blood sugar levels, systolic blood pressure, and non-HDL cholesterol levels.

How Does Foundayo Cause Weight Loss?

Orforglipron, the active ingredient in Foundayo, is a small-molecule drug that binds to and activates the GLP-1 receptor. This stimulates signalling pathways that produce the same physiological effects as the naturally occurring gut hormone GLP-1, including:

• Enhanced insulin secretion from the pancreas
• Slowed gastric emptying
• Improved appetite regulation and increased satiety

Delayed gastric emptying (i.e., the rate at which food moves through the stomach) can make Foundayo users feel ‘full’ more quickly after eating. Foundayo’s effects on the brain, which further increase satiety, can also help to reduce food intake. As a result, people using Foundayo typically feel less hungry and experience fewer food cravings, making it easier to reduce their calorie intake.

How Quickly Do You Lose Weight on Foundayo?

Foundayo enters your bloodstream rapidly and reaches peak blood concentrations within hours of taking the first pill. However, it can take weeks for the medication's weight loss effects to begin. This is because the starting dose of Foundayo (0.8 mg) is an initiation dose intended to help your body adjust to the medication, rather than a full therapeutic dose.
Individual responses to the Foundayo starting dose can vary, but some people notice reduced appetite and ‘food noise’ within the first few weeks of treatment. Clinical studies have observed modest weight loss after just one month on Foundayo, but the most substantial weight loss occurs after several months on the medication.

Foundayo Weight Loss Timeline 

As with other GLP-1 medications, users increase their Foundayo dosage over a series of months. Foundayo treatment starts with a once-daily dose of 0.8 mg, increasing to 2.5 mg after at least 30 days. You can further increase your dose to 5.5 mg, 9 mg, 14.5 mg, and finally 17.2 mg, staying on each dose for at least 30 days and titrating up only if your current dose is well tolerated.

Foundayo's effects are dose-dependent, with the most substantial weight reductions linked to higher doses. Therefore, weight loss often builds over several months of treatment, though the rate varies by dosage and individual response. Here, we’ll examine the likely weight loss effects of Foundayo at different stages over a full year of treatment and beyond.

Months 1-3

During months 1-3, Foundayo users can increase their dose from 0.8 mg (the starting dose) to 2.5 mg, then 5.5 mg, if they titrate up every 30 days. The early stages of Foundayo treatment allow your body to adjust to the medication, but may not produce significant weight loss.

​However, some people may see weight loss effects from Foundayo as early as month 1 of treatment. One study found that Foundayo users reduced their food intake after 4 weeks on the drug and reported a decrease in hunger and an increase in fullness. Therefore, by month 3, many people will have started losing weight because of their reduced calorie intake.

Months 4-6

Weight loss on Foundayo often becomes more meaningful over months 4-6 as participants increase their dosage. People who increase their dose every 30 days will reach the maximum dose (17.2 mg) after 5 months of treatment. One study found that, by week 26, orforglipron users had shed an average of 8.6% of their starting body weight on a 9 mg dose, and 11.2% on a 14.5 mg dose. How much weight you lose during this time depends heavily on your dosage.

Months 7-9

From months 7-9 of Foundayo treatment, users typically continue losing weight at a substantial rate, especially if they have titrated up to the highest dose. One study found that participants lost 9.4%-14.7% of their total body weight by month 9, depending on their orforglipron dosage. The researchers also noted that weight loss didn’t appear to plateau by month 9, suggesting it would continue with ongoing treatment.

Months 10-12

By month 10 of Foundayo treatment, you may still be losing weight, or you may have reached a weight loss plateau. Your total weight loss will heavily depend on your Foundayo dose and individual response, but the ATTAIN-1 clinical trial reported weight reductions of up to 12.4% on the highest dose of orforglipron, after 72 weeks of treatment. If you have stopped losing weight, you can keep taking Foundayo to maintain your lower weight. 

Beyond Year One

You can keep taking Foundayo even after your weight loss has plateaued, and continuing treatment beyond year one may help you maintain your lower weight. Most people regain a large proportion of the weight lost on GLP-1 medications after they quit, as their appetite returns and food intake increases.

​The ATTAIN-1 trial demonstrated that orforglipron users maintained their lower weight between weeks 48 and 72 of continued treatment. Another study of people using orforglipron following tirzepatide treatment found that participants maintained around 75% of their weight loss with the help of Foundayo.

Foundayo (Orforglipron)

Rated 0 out of 5 based on 0 reviews

Rated 0 out of 5 based on 0 reviews

• Oral GLP-1 tablet
• Manufactured by Eli Lilly
• Clinical trials show weight loss of around 12.4% after 72 weeks

• Discreet delivery next working day
• Online prescription - No doctor visit

Prices from £109.00 Review More Prices

Start Order More Info

Get Started

Start Order More info

Factors that Affect Weight Loss on Foundayo

Several factors may affect your rate and amount of weight loss on Foundayo, including dosage, treatment length, starting body weight, and lifestyle.

• Dosage: Foundayo’s effects are dose-dependent, with higher doses typically producing the greatest weight reductions. Therefore, users who titrate up to the highest possible dose (17.2 mg) are likely to lose more weight overall than those who maintain a lower dose.
• Length of Treatment: Weight loss on Foundayo can begin as early as 4 weeks into treatment and is usually progressive, with weight loss building over several months before plateauing. The longer you continue treatment, the more weight you are likely to lose.
• Starting Body Weight: Baseline BMI doesn’t appear to affect orforglipron’s efficacy, but your starting weight can heavily influence the total amount of weight lost. For example, a 10% body weight reduction would mean losing 8 kg for an 80 kg person, or 10 kg for someone weighing 100 kg at the start of treatment.
• Lifestyle Factors: Diet and exercise are key elements of an integrated weight management plan. Doctors recommend using Foundayo as an adjunct to a reduced-calorie diet and increased physical activity. Making dietary adjustments (for example, avoiding high-fat and sugary foods) can help to decrease your calorie intake and, therefore, accelerate weight loss. Developing better exercise habits can also support long-term weight loss maintenance and help preserve muscle mass.

Foundayo Weight Loss Comparisons

Learning about possible Foundayo weight loss results is helpful, but how does the treatment compare with other popular anti-obesity medications? This table has all the answers.

As you can see, potential Foundayo weight loss results are comparable to oral semaglutide (Wegovy) and greater than Mysimba. Although it lags behind the injections, this is somewhat offset by the more straightforward administration and the lack of worrying about needles.

If you’d like more information about which weight loss medication might be best for your circumstances, our experienced clinicians are here to help.

Frequently Asked Questions

Starting a new weight loss treatment plan requires careful consideration, and many people want to know about the long-term effects of Foundayo. We’ll answer some of the most common queries around Foundayo weight loss and weight loss maintenance below.

Does Foundayo Help Maintain Weight Loss?

Research suggests that Foundayo may help people maintain their weight loss, either when used alone or as a follow-on treatment after discontinuing another GLP-1 medication. The ATTAIN-1 clinical trial, which assessed the efficacy of orforglipron for weight loss over 72 weeks, demonstrated that users maintained their lower weight throughout treatment.

Another study of people using Foundayo after discontinuing tirzepatide (Mounjaro) therapy found that it could help to prevent weight regain. People taking orforglipron preserved around three-quarters of the weight they lost on the injections, while those taking a placebo maintained only 49% of their weight loss.

Is Foundayo Weight Loss Permanent?

Foundayo weight loss is not necessarily permanent. This is because the appetite-suppressing effects of GLP-1 medications only persist for as long as you continue treatment. If you stop taking the medication, your hunger levels (and calorie intake) will probably increase, and this frequently leads to weight regain.

One study found that people who stopped using other weight loss medicines regained an average of 60% of their weight loss in the year after stopping. However, there are currently no studies on long-term withdrawal from Foundayo treatment.

How Much Can I Expect to Lose With Foundayo?

Clinical trials provide weight loss estimates of 12.4% with Foundayo treatment. However, each person’s weight loss journey is unique, and results may vary. Numerous factors, including lifestyle, starting weight, dosage, side-effect tolerance, and treatment duration, influence individual responses to Foundayo.

A Bespoke Weight Loss Service

Everyone’s weight loss journey is different, so it’s important to find the right regimen that works for you. Prescription Doctor is perfectly placed to do just that. Since 2013, we’ve supported countless individuals in achieving their goals, and we’re ready to do the same for you.Our service begins with a simple online questionnaire that helps determine whether a particular medication is suitable for your circumstances, or whether an alternative treatment would be more beneficial. Our experienced clinicians are also available to answer any questions about our programme, so you can get the support you need.

Once approved, your order is dispatched by our General Pharmaceutical Council-registered pharmacy to your designated UK address in plain packaging for complete discretion. Orders approved before 3pm on a weekday are also eligible for next-day delivery. It’s that straightforward.

We don’t stop there, either, as our clinicians regularly monitor your progress to ensure everything is working as it should, and support you with any queries along the way. You can also access a library of useful information about weight loss medications on our website. It’s therefore no surprise that we’ve cultivated a strong reputation for the quality of our service.

If you’re ready to be part of a service that’s built around you, start a consultation with Prescription Doctor today. 
 

Authored & Reviewed By

Mohamed Imran Lakhi

MPharm - Lead Pharmacist

Imran Lakhi is the superintendent pharmacist and founder at Prescription Doctor. He has been at the core of our team.

Published on: 11/11/2026 Reviewed on: 11/11/2026